Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GH-21 by HUYA Bioscience International for Solid Tumor: Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Solid Tumor. According to GlobalData,...
Tucidinostat by HUYA Bioscience International for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Tucidinostat is under clinical development by HUYA Bioscience International and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL)....
Tucidinostat by HUYA Bioscience International for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Tucidinostat is under clinical development by HUYA Bioscience International and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL)....
GH-21 by HUYA Bioscience International for Non-Small Cell Lung Cancer: Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Non-Small Cell Lung Cancer. According...